University of Nottingham — Endocannabinoid Research Group
Nottingham, United KingdomFounded 2012
About University of Nottingham — Endocannabinoid Research Group
Nottingham's endocannabinoid research group studies the role of the endocannabinoid system in cardiovascular health, metabolic disease, and inflammatory conditions.
Key Facts
- 1Led by Prof. Saoirse O'Sullivan, a globally cited expert on cannabinoids and cardiovascular pharmacology
- 2Published influential studies on CBD's effects on blood pressure and vascular function
Frequently Asked Questions
What has Nottingham found about CBD and heart health?
The group published studies showing CBD can reduce blood pressure and arterial stiffness in controlled settings, though clinical translation is ongoing.
Does the group study THC too?
The group studies the full endocannabinoid system, including THC, CBD, endogenous cannabinoids, and synthetic analogs.
More Cannabis Companies in Nottingham
Cannabis Laws
Products
- Endocannabinoid system publications
- Cardiovascular research data
Specialties
Endocannabinoid cardiovascular researchMetabolic syndrome studies
Company Details
- Location
- Nottingham, United Kingdom
- Founded
- 2012
- Publicly Traded
- No
Browse all Consulting & Education
View more companies in this category
Related Companies
More in United Kingdom
Kanabo Group
London \u2014 Medical & Pharma
Cellular Goods
London \u2014 CBD & Hemp
MGC Pharmaceuticals
London \u2014 Medical & Pharma
Sapphire Medical Clinics
London \u2014 Medical & Pharma